Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction - PubMed (original) (raw)
. 2008 Sep;33(9):1845-51.
doi: 10.1007/s11064-008-9646-4. Epub 2008 Mar 20.
Affiliations
- PMID: 18351462
- DOI: 10.1007/s11064-008-9646-4
Glucagon-like peptide-1 (GLP-1) diminishes neuronal degeneration and death caused by NGF deprivation by suppressing Bim induction
Subhas C Biswas et al. Neurochem Res. 2008 Sep.
Abstract
Glucagon-like peptide-1 (GLP-1) is a glucoincretin hormone most intensively studied for its actions on insulin secreting beta-cells. GLP-1 and its receptor are also found in brain and accumulating evidence indicates that GLP-1 has neuroprotective actions. Here, we investigated whether GLP-1 protects neuronal cells from death evoked by nerve growth factor (NGF) withdrawal. Compromised trophic factor signaling may underlie neurodegenerative diseases ranging from Alzheimer disease to diabetic neuropathies. We report that GLP-1 provides sustained protection of cultured neuronal PC12 cells and sympathetic neurons from degeneration and death caused by NGF deprivation. Past work shows that NGF deprivation induces the pro-apoptotic protein Bim which contributes to neuron death. Here, we find that GLP-1 suppresses Bim induction promoted by NGF deprivation. Thus, GLP-1 may protect neurons, at least in part, by suppressing Bim induction. Our findings support the idea that drugs that mimic or elevate GLP-1 represent potential therapeutics for neurodegenerative diseases.
Similar articles
- Pro-apoptotic Bim induction in response to nerve growth factor deprivation requires simultaneous activation of three different death signaling pathways.
Biswas SC, Shi Y, Sproul A, Greene LA. Biswas SC, et al. J Biol Chem. 2007 Oct 5;282(40):29368-74. doi: 10.1074/jbc.M702634200. Epub 2007 Aug 16. J Biol Chem. 2007. PMID: 17702754 - Efficacy of cyclin dependent kinase 4 inhibitors as potent neuroprotective agents against insults relevant to Alzheimer's disease.
Sanphui P, Pramanik SK, Chatterjee N, Moorthi P, Banerji B, Biswas SC. Sanphui P, et al. PLoS One. 2013 Nov 11;8(11):e78842. doi: 10.1371/journal.pone.0078842. eCollection 2013. PLoS One. 2013. PMID: 24244372 Free PMC article. - The pro-apoptotic protein Bmf co-operates with Bim and Puma in neuron death induced by β-amyloid or NGF deprivation.
Akhter R, Saleem S, Saha A, Biswas SC. Akhter R, et al. Mol Cell Neurosci. 2018 Apr;88:249-257. doi: 10.1016/j.mcn.2018.02.011. Epub 2018 Feb 27. Mol Cell Neurosci. 2018. PMID: 29499358 - Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
Lee YS, Jun HS. Lee YS, et al. Metabolism. 2014 Jan;63(1):9-19. doi: 10.1016/j.metabol.2013.09.010. Epub 2013 Oct 17. Metabolism. 2014. PMID: 24140094 Review. - NGF deprivation-induced gene expression: after ten years, where do we stand?
Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA, Xie L. Freeman RS, et al. Prog Brain Res. 2004;146:111-26. doi: 10.1016/S0079-6123(03)46008-1. Prog Brain Res. 2004. PMID: 14699960 Review.
Cited by
- The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease.
Du H, Meng X, Yao Y, Xu J. Du H, et al. Front Endocrinol (Lausanne). 2022 Nov 17;13:1033479. doi: 10.3389/fendo.2022.1033479. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36465634 Free PMC article. Review. - Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.
Chapter MC, White CM, DeRidder A, Chadwick W, Martin B, Maudsley S. Chapter MC, et al. Pharmacol Ther. 2010 Jan;125(1):39-54. doi: 10.1016/j.pharmthera.2009.07.006. Epub 2009 Aug 15. Pharmacol Ther. 2010. PMID: 19686775 Free PMC article. Review. - DPP-4 inhibitors: a promising therapeutic approach against Alzheimer's disease.
Angelopoulou E, Piperi C. Angelopoulou E, et al. Ann Transl Med. 2018 Jun;6(12):255. doi: 10.21037/atm.2018.04.41. Ann Transl Med. 2018. PMID: 30069457 Free PMC article. Review. - Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.
Salcedo I, Tweedie D, Li Y, Greig NH. Salcedo I, et al. Br J Pharmacol. 2012 Jul;166(5):1586-99. doi: 10.1111/j.1476-5381.2012.01971.x. Br J Pharmacol. 2012. PMID: 22519295 Free PMC article. Review. - Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway.
Liu JH, Yin F, Guo LX, Deng XH, Hu YH. Liu JH, et al. Acta Pharmacol Sin. 2009 Feb;30(2):159-65. doi: 10.1038/aps.2008.25. Epub 2009 Jan 19. Acta Pharmacol Sin. 2009. PMID: 19151742 Free PMC article.
References
- Ann N Y Acad Sci. 2000;921:242-50 - PubMed
- J Pharmacol Exp Ther. 2002 Mar;300(3):958-66 - PubMed
- Biochem Pharmacol. 2000 Oct 15;60(8):1015-21 - PubMed
- Neuroendocrinology. 1995 Aug;62(2):130-4 - PubMed
- J Neurosci. 1998 Feb 1;18(3):830-40 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous